Barclays Maintains Overweight on uniQure, Lowers Price Target to $60

uniQure N.V.

uniQure N.V.

QURE

0.00

Barclays analyst Eliana Merle maintains uniQure (NASDAQ: QURE) with a Overweight and lowers the price target from $65 to $60.